IL233543B - Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4- positive cancer in a mammalian subject - Google Patents

Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4- positive cancer in a mammalian subject

Info

Publication number
IL233543B
IL233543B IL233543A IL23354314A IL233543B IL 233543 B IL233543 B IL 233543B IL 233543 A IL233543 A IL 233543A IL 23354314 A IL23354314 A IL 23354314A IL 233543 B IL233543 B IL 233543B
Authority
IL
Israel
Prior art keywords
methods
cancer
diagnosing
mammals
detecting circulating
Prior art date
Application number
IL233543A
Other languages
English (en)
Hebrew (he)
Other versions
IL233543A0 (en
Original Assignee
Pfizer
Epic Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Epic Sciences Inc filed Critical Pfizer
Publication of IL233543A0 publication Critical patent/IL233543A0/en
Publication of IL233543B publication Critical patent/IL233543B/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5759
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • G01N33/575
    • G01N33/5758
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70589CD45

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
IL233543A 2012-01-24 2014-07-07 Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4- positive cancer in a mammalian subject IL233543B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261590066P 2012-01-24 2012-01-24
US201361753665P 2013-01-17 2013-01-17
PCT/IB2013/050547 WO2013111054A1 (en) 2012-01-24 2013-01-22 Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject

Publications (2)

Publication Number Publication Date
IL233543A0 IL233543A0 (en) 2014-08-31
IL233543B true IL233543B (en) 2018-02-28

Family

ID=47844410

Family Applications (1)

Application Number Title Priority Date Filing Date
IL233543A IL233543B (en) 2012-01-24 2014-07-07 Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4- positive cancer in a mammalian subject

Country Status (14)

Country Link
US (1) US10254286B2 (enExample)
EP (1) EP2807485B1 (enExample)
JP (1) JP6254951B2 (enExample)
KR (1) KR101716555B1 (enExample)
CN (1) CN104094116B (enExample)
AU (2) AU2013213301A1 (enExample)
BR (1) BR112014018192A8 (enExample)
CA (1) CA2861437C (enExample)
ES (1) ES2724232T3 (enExample)
IL (1) IL233543B (enExample)
IN (1) IN2014DN07019A (enExample)
MX (1) MX361058B (enExample)
RU (1) RU2646498C2 (enExample)
WO (1) WO2013111054A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2803804B2 (ja) 1992-08-21 1998-09-24 株式会社長澤製作所 ボタン錠
AU2010310688A1 (en) 2009-10-21 2012-05-17 Epic Sciences, Inc. Method of using non-rare cells to detect rare cells
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
EA201691352A1 (ru) * 2013-12-30 2016-11-30 Дзе Скриппс Рисерч Инститьют Диагностика рака легкого с помощью циркулирующих опухолевых клеток
WO2015112955A1 (en) 2014-01-27 2015-07-30 Epic Sciences, Inc. Circulating tumor cell diagnostics for prostate cancer biomarkers
US10545151B2 (en) * 2014-02-21 2020-01-28 Epic Sciences, Inc. Methods for analyzing rare circulating cells
WO2015155345A1 (en) * 2014-04-11 2015-10-15 Medimmune Limited Antibodies and antibody-drug conjugates
EA201692223A1 (ru) * 2014-05-09 2017-04-28 Дзе Скриппс Рисерч Инститьют Композиции и способы жидкостной биопсии меланомы
US10871491B2 (en) * 2014-08-25 2020-12-22 Creatv Microtech, Inc. Use of circulating cell biomarkers in the blood for detection and diagnosis of diseases and methods of isolating them
CN113552350B (zh) * 2015-04-21 2024-10-11 基因泰克公司 用于前列腺癌分析的组合物和方法
CN114480574A (zh) * 2015-11-06 2022-05-13 文塔纳医疗系统公司 代表性诊断
KR102478639B1 (ko) 2016-02-23 2022-12-19 노을 주식회사 표지 물질을 저장하는 패치, 이를 이용하는 조직 진단 방법 및 장치
US10371610B2 (en) 2016-02-23 2019-08-06 Noul Co., Ltd. Contact-type patch, staining method using the same, and manufacturing method thereof
KR102406596B1 (ko) * 2016-02-23 2022-06-10 노을 주식회사 패치를 이용하는 ctc 진단 방법 및 장치
KR102045068B1 (ko) * 2016-02-23 2019-11-15 노을 주식회사 중합 효소 연쇄 반응 패치, 이를 이용하는 진단 방법 및 장치
KR20170099738A (ko) 2016-02-23 2017-09-01 노을 주식회사 접촉식 염색 패치 및 그 제조 방법
WO2018184966A1 (en) 2017-04-03 2018-10-11 F. Hoffmann-La Roche Ag Antibodies binding to steap-1
WO2019005902A1 (en) * 2017-06-27 2019-01-03 Qcdx, Llc SYSTEM AND METHODS FOR DIAGNOSING QUANTITATIVE LIQUID BIOPSY
CN107918013A (zh) * 2017-09-25 2018-04-17 浙江天科高新技术发展有限公司 化学发光酶免测定循环肿瘤细胞中K‑Ras蛋白的方法及试剂盒
JP7678424B2 (ja) 2018-05-10 2025-05-16 学校法人順天堂 画像解析方法、装置、コンピュータプログラム、及び深層学習アルゴリズムの生成方法
US20220002429A1 (en) * 2018-10-24 2022-01-06 Northwestern University Tumor cell aggregation inhibitors' for treating cancer
JP7381003B2 (ja) * 2019-04-26 2023-11-15 学校法人順天堂 疾患解析を支援する方法、装置、及びコンピュータプログラム、並びにコンピュータアルゴリズムを訓練する方法、装置、及びプログラム
WO2023107566A1 (en) 2021-12-07 2023-06-15 Epic Sciences, Inc. Enhanced characterization of breast cancer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391904A (en) 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
EP0336562B1 (en) 1988-03-04 1995-06-14 Cancer Research Campaign Technology Ltd. Improvements relating to antigens
US5869053A (en) 1988-03-04 1999-02-09 Cancer Research Campaign Technology, Ltd. 5T4 antigen from human trophoblasts
IL132596A0 (en) 1997-06-04 2001-03-19 Oxford Biomedica Ltd Vector
AU1290001A (en) 1999-11-18 2001-05-30 Oxford Biomedica (Uk) Limited Antibodies
GB0126378D0 (en) 2001-11-02 2002-01-02 Oxford Biomedica Ltd Antigen
US7305112B2 (en) 2002-10-15 2007-12-04 The Scripps Research Institute Method of converting rare cell scanner image coordinates to microscope coordinates using reticle marks on a sample media
RU2007108716A (ru) * 2004-09-10 2008-10-20 Вайет (Us) Гуманизированные антитела к антигену 5т4 и конъюгаты гуманизированного антитела к антигену 5т4 с калихеамицином
WO2007089911A2 (en) * 2006-01-30 2007-08-09 The Scripps Research Institute Methods for detection of circulating tumor cells and methods of diagnosis of cancer in a mammalian subject
TWI421257B (zh) 2006-03-10 2014-01-01 Wyeth Corp 抗5t4抗體及其用途
WO2008131048A2 (en) 2007-04-16 2008-10-30 Cellpoint Diagnotics, Inc. Devices and methods for diagnosing, prognosing, or theranosing a condition by enriching rare cells
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method
CN102414562B (zh) 2009-03-24 2019-05-07 生物概念股份有限公司 细胞捕获和分析的装置和方法
JP5788863B2 (ja) 2009-03-27 2015-10-07 ワイス・エルエルシー 腫瘍開始細胞およびその使用方法
JP2013504064A (ja) 2009-09-03 2013-02-04 ザ スクリプス リサーチ インスティチュート 循環腫瘍細胞を分類する方法
AU2010310688A1 (en) 2009-10-21 2012-05-17 Epic Sciences, Inc. Method of using non-rare cells to detect rare cells
EP2556172A4 (en) * 2010-04-06 2013-10-30 Caris Life Sciences Luxembourg Holdings CIRCULATING BIOMARKERS FOR DISEASES
DK2591363T3 (en) 2010-07-07 2017-12-11 Univ Michigan Regents DIAGNOSIS AND TREATMENT OF BREAST CANCER
BR112013025186A2 (pt) 2011-04-01 2018-09-11 Wyeth Llc conjugados de anticorpo-fármaco

Also Published As

Publication number Publication date
US10254286B2 (en) 2019-04-09
EP2807485B1 (en) 2019-03-13
AU2018220154A1 (en) 2018-09-13
BR112014018192A8 (pt) 2021-03-02
KR101716555B1 (ko) 2017-03-14
MX2014008928A (es) 2014-10-24
RU2014127474A (ru) 2016-03-20
KR20140100580A (ko) 2014-08-14
IL233543A0 (en) 2014-08-31
JP6254951B2 (ja) 2017-12-27
ES2724232T3 (es) 2019-09-09
CN104094116B (zh) 2017-05-31
RU2646498C2 (ru) 2018-03-05
AU2013213301A1 (en) 2014-07-17
CA2861437C (en) 2018-08-21
EP2807485A1 (en) 2014-12-03
MX361058B (es) 2018-11-23
CN104094116A (zh) 2014-10-08
HK1202923A1 (en) 2015-10-09
US20150017661A1 (en) 2015-01-15
JP2015507190A (ja) 2015-03-05
IN2014DN07019A (enExample) 2015-04-10
CA2861437A1 (en) 2013-08-01
WO2013111054A1 (en) 2013-08-01

Similar Documents

Publication Publication Date Title
IL233543A0 (en) Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4- positive cancer in a mammalian subject
PT2836511T (pt) Polipéptido útil em terapia celular adotiva
IL234850B (en) Rapid aneuploidy detection
LT2734307T (lt) Kraujyje cirkuliuojančių daugybinės mielomos ląstelių fiksavimo ir nustatymo testas
EP2847593A4 (en) METHODS FOR PREDICTING AND DETECTING THE RISK OF CANCER
EP3082840A4 (en) Methods and assays relating to circulating tumor cells
IL225646A0 (en) Methods and kits for detecting cancer cells in the circulation of pancreatic patients using polyspecific capture and cocktail detection reagents
IL235738B (en) Method for quantifying immune cells in tumoral tissues and its applications
EP3083658A4 (en) Methods and assays relating to circulating tumor cells
BR112015008210A2 (pt) métodos e sistemas de concentrador de oxigênio dual.
EP2833149A4 (en) METHOD FOR DETECTING THE MALIGNANCE DEGREE OF A CIRCULATING TUMOR CELL UNIT AND KIT THEREFOR
BR112013020689A2 (pt) sistema de células de combustível com recirculação integrada
EP2529223A4 (en) BIOMARKERS FOR CIRCULATING TUMOR CELLS
DE112012006188B8 (de) Brennstoffzellensystem
DK2814945T3 (da) Celle med reduceret ppgppase-aktivitet
IL235125A0 (en) Microbial fuel cell
DE112012006314B8 (de) Brennstoffzellensystem
DE112013002725B8 (de) Brennstoffzellensystem
EP2885829A4 (en) LOADING COLLECTORS AND RELATED METHODS
DK2920282T3 (da) Alkylenkoblede phenoler til anvendelse i biodieselmotorer
DE112012006025B8 (de) Brennstoffzellensystem
SG10201705269TA (en) Fuel cell system with interconnect
EP2795304A4 (en) ELECTROCHEMICAL SENSORS
IL232642A0 (en) Method for characterizing circulating tumor cells, and use thereof in diagnosis
EP2830138A4 (en) BIOFUELS BATTERY

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed